Shell Stocks; Reverse Mergers; Acquisitions; Zombies; Greys; & All "Other" Plays

[Potse]

GSAC(.0033)...Mastix issued cannabis-related patent allowance.....

Added a few more shares to my position. GSAC continues to be a largely under-followed sub-penny play with connections to the cannabis sector. GSAC's involvement in the cannabis sector comes in the form of its contract manufacturing business (gum, lozenges, confectionery products, etc), pending patents on its manufacturing processes, and its own proprietary brands of CBD-infused products.

The stock is trading at a pretty steep discount to the 7 cent share price it was trading at when it acquired Mastix Medica in 2014.

Picked up some more shares to add to my GSAC position. Extremely high-risk investment because of a lack of updated information since mid-2016. Always a risk/concern undisclosed material events could have occurred since the last public disclosures, and in the process made the company/stock less attractive.

But if Mastix Medica (Mastix LLC) still remains a wholly-owned subsidiary of GSAC, then this stock continues to look pretty interesting at this price level. Especially when you consider the kinds of stratospheric market capitalizations that other cannibas-related stocks have been attaining.

Mastix received a patent allowance last week.....

New U.S. Patent Allowance Granted to Mastix LLC for a New Chewing Gum Manufacturing Method Incorporating Cannabinoids

Allows Unique Manufacturing Process for Chewing Gum Products Used to Deliver Active Ingredients Including CBD and THC

HUNT VALLEY, MD, July 25, 2017 /24-7PressRelease/ -- Mastix LLC, a leading manufacturer of innovative functional supplement products, today announces that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application 14/732,072, a utility patent that claims a new manufacturing method for functional chewing gum that covers powder and oil-based active ingredients, including cannabidiol (CBD) and tetrahydrocannabinol (THC). This platform patent technology covers the inclusion of a wide range of active ingredients, including cannabinoids (both naturally extracted and synthetically derived), which is a market experiencing explosive growth.

"The granting of this notice of allowance for our novel chewing gum dosage form validates the innovative nature of our platform technology and positions us well to offer our customers and consumers an alternative delivery system to pills, capsules and beverages that is widely acceptable and very familiar," said Bob Estey, CEO of Mastix. "We have the unique ability to incorporate either a single active ingredient, or multiple active ingredients, into the gum tablets we make to provide our customers with truly custom chewing gum products that will now be patent protected. Consumers are actively seeking alternative delivery vehicles for the many pharmaceutical and supplement products they currently take as pills or capsules. Chewing gum is a convenient and discrete way for consumers to quickly and efficiently deliver the benefits they expect from the products they use to improve their health and wellness. The extensive clinical studies the US Military performed on our caffeine gum proved that gum delivered through the oral mucosa is up to five times faster than swallowing pills or capsules while also maintaining high bioavailability of the active."

In addition to its proprietary CBD gum (www.medcbdx.com), Mastix offers custom development, contract manufacturing and private label for its chewing gum, lozenge and chewable tablet products. Mastix has developed tableted products in a wide range of active ingredients including dietary supplements, herbal extracts, probiotics and cannabinoids, and is best known as the supplier of caffeine chewing gum for the US Military ration kits.

About Mastix LLC

Mastix LLC develops, manufactures and markets niche functional food and dietary supplement products in chewing gum, chewable tablet and lozenge dosage formats. Mastix manufactures its products in full compliance with FDA GMP regulations.

http://www.prnewswire.com/news-releases/new-us-patent-allowance-granted-to-mastix-llc-for-a-new-chewing-gum-manufacturing-method-incorporating-cannabinoids-300493344.html